Log In
BCIQ
Print this Print this
 

Prostate-specific antigen (KLK3) (PSA)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Prostate-specific antigen (KLK3) (PSA)

BCIQ
Print ChartPrint this
Marketed, 1 Phase III, 1 Phase I/II, 1 Phase I, 1 Pilot, 1 Preclinical, 1 Preclinical, 3 Discovery, 1
Phase of DevelopmentDiscoveryPreclinicalPilotPhase IPhase I/IIPhase IIIMarketed
Cancer

1

3

-

1

1

1

-

Diagnostic

-

1

1

-

-

-

1




 Products Targeting Prostate-specific antigen (KLK3) (PSA)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

5

$460.8M

$0.0M

$33.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today